 Cytarabine neurologic toxicity Cytarabine effective drug treatment certain hematologic malignancies common toxicities myelosuppression gastrointestinal disturbance past decade neurotoxicity cytarabine effect Intrathecal IT cytarabine myelopathy reversible IT drug cranial irradiation leukoencephalopathy Intravenous IV therapy peripheral neuropathy severity high IV cytarabine doses seizures cerebral dysfunction acute cerebellar syndrome incidence Patient age years important risk factor drug dose/schedule cumulative drug dose renal hepatic dysfunction concomitant use neurotropic antiemetic agents risk neurotoxicity understanding pathophysiology pharmacology cytarabine-induced neuronal injury drug efficacy safety